Table1.
Patient's characteristics
| Characteristics | n | % |
| Age, years | ||
| Median | 53 | |
| Range | 36-72 | |
| Gender | ||
| Males | 12 | 67 |
| Females | 6 | 33 |
| Tumor grade | ||
| Grade 1 | 1 | 6 |
| Grade 2 | 11 | 61 |
| Grade 3 | 6 | 33 |
| Performance status (ECOG) | ||
| 0 | 4 | 22 |
| 1 | 5 | 28 |
| 2 | 6 | 33 |
| 3 | 3 | 17 |
| Type of previous surgery | ||
| Curative | 5 | 28 |
| Palliative | 11 | 61 |
| Both (curative/palliative) | 2 | 11 |
| Type of previous chemotherapy regimen (first line) | ||
| Oxaliplatin-based chemotherapy | 8 | 44 |
| Irinotecan-based chemotherapy | 10 | 56 |
| Number of involved organs | ||
| 1 | 7 | 39 |
| 2 | 8 | 44 |
| ≥ | 3 | 17 |
| Sites affected | ||
| Liver | 9 | 50 |
| Lung | 7 | 39 |
| Peritoneal | 2 | 11 |
| Lymph nodes | 6 | 33 |